AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

The Impact of COVID-19 on Kidney Health

  • Credit:1.0 ACCENT
  • Duration: 1 Hour
  • Date:SEP.16.2021 1:00 p.m. - 02:00 p.m.
  • Level: Basic

Price: $0.00

Member Price: $0.00

Rating: Member Average

All webinar times are in Eastern Time except where noted. Convert to your time zone

Register for this live webinar to learn about the importance of urinalysis in screening for kidney health. During this hour you will have the opportunity to engage in live Q&A with faculty. With your registration, you will have access to the recording on demand through September 30, 2022.

DESCRIPTION

During the pandemic, routine testing has been disrupted, but urinalysis is important in screening for kidney health. Point-of-care urinalysis plays a pivotal role in the screening and early detection of kidney damage. Dr. Nadkarni and Nancy Brunzel share their expertise in screening for chronic kidney disease pre- and post-pandemic.

Nancy Brunzel, assistant professor at the University of Minnesota, is the author of Fundamentals of Urine and Body Fluid Analysis, covering the collection and analysis of urine and other body fluids. Ms. Brunzel will share her extensive knowledge and expertise in the field by presenting the background of urinalysis, policies and procedures, technology used for urinalysis, and defining urinalysis’ many uses. This presentation will cover the importance of screening for chronic kidney disease and how urinalysis can be used for such screening.

Dr. Girish Nadkarni is an associate professor in the Department of Medicine, Division of Nephrology, The Mount Sinai Hospital; clinical director of the Hasso Plattner Institute for Digital Health; and co-director of the Mount Sinai COVID Informatics Center. Dr. Nadkarni and team developed and executed a retrospective, observational study that reviewed data from electronic health records of patients aged 18 years or older with laboratory-confirmed COVID-19 admitted to the Mount Sinai Health System. He will present his findings from this study and best practices for screening for CKD and AKI in COVID-19 patients.

TARGET AUDIENCE

This activity is designed for point of care coordinators, nurses (especially nephrology nurses and technicians), physicians, nephrologists, urologists, endocrinologists, clinicians, patients, providers, researchers.

LEARNING OBJECTIVES

At the end of this activity, participants will be able to:

  • Identify the role urinalysis plays in screening for kidney health.
  • Identify how urinalysis has been used in screening for CKD and AKI in patients who may or may not have contracted COVID-19.
  • Explain the role of urinalysis in kidney health to predict COVID-19 severity.

FACULTY

Nancy BrunzelNancy Brunzel, MS, MLS(ASCP)CM
Assistant Professor (Retired)
University of Minnesota
Minneapolis, MN

Girish Nadkarni HeadshotGirish Nadkarni, MD, MPH
Associate Professor, Division of Nephrology
Mount Sinai Hospital
New York, NY

DISCLOSURES AND STATEMENT OF INDEPENDENCE

AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Nancy Brunzel, MS, MLS(ASCP)CM

  • Consultant Fee: Siemens Healthcare Diagnostics
  • Intellectual Property/Royalty Income: Elsevier, Inc. - publisher

Girish Nadkarni, MD, MPH

  • Consultant Fee: Renalytix, Reata, AstraZeneca, BioVie, GLG consulting
  • Board/Committee Membership/Advisory Board:Renalytix
  • Stocks/Bonds: Renalytix, Verici
  • Presenter/Speaker: Renalytix
  • Intellectual Property/Royalty Income: Renalytix

CONTENT VALIDITY

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

ACCREDITATION STATEMENT

This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 2149. This activity was planned in accordance with ACCENT® Standards and Policies.

SUCCESSFUL COMPLETION STATEMENT

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].

Sponsored by

siemens logo